跳至主要内容
临床试验/NCT03251261
NCT03251261已完成不适用

Illumigene CMV Clinical Trial Protocol

Meridian Bioscience, Inc.5 个研究点 分布在 4 个国家目标入组 1,615 人开始时间: 2017年8月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,615
试验地点
5
主要终点
Qualitative detection of CMV to aid in the diagnosis of CMV

研究概览

简要总结

To evaluate the illumigene CMV assay, using the illumipro-10 with neonates (up to 21 days of age) saliva swabs

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 20 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Saliva swab specimens from neonates up to 21 days of age
  • Saliva swab sample placed in a nonnutritive transport medium or in a plastic sterile tube without medium.
  • Flocked-nylon swabs

排除标准

  • Samples other than saliva swab from patients up to 21 days of age.
  • Swabs other than flocked-nylon.
  • Swabs in a viral transport media not defined in the Investigational Use Only package insert
  • Multiple specimens from the same patient.
  • Specimens received in the laboratory in unsatisfactory containers or condition.

结局指标

主要结局

Qualitative detection of CMV to aid in the diagnosis of CMV

时间窗: within 30 days of sample collection

Test each sample for CMV detection

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Detection of Cytomegalovirus Virus in Neonates | 临床试验